In vivo 19F MRI and 19F MRS of 19F- labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT)

Paola Porcari, Silvia Capuani, Emanuela D'Amore, Mario Lecce, Angela La Bella, Fabrizio Fasano, Renzo Campanella, Luisa Maria Migneco, Francesco Saverio Pastore, Bruno Maraviglia

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Boron neutron capture therapy (BNCT) is a promising binary modality used to treat malignant brain gliomas. To optimize BNCT effectiveness a non-invasive method is needed to monitor the spatial distribution of BNCT carriers in order to estimate the optimal timing for neutron irradiation. In this study, in vivo spatial distribution mapping and pharmacokinetics evaluation of the 19F-labelled boronophenylalanine (BPA) were performed using 19F magnetic resonance imaging (19F MRI) and 19F magnetic resonance spectroscopy (19F MRS). Characteristic uptake of 19F-BPA in C6 glioma showed a maximum at 2.5 h after compound infusion as confirmed by both 19F images and 19F spectra acquired on blood samples collected at different times after infusion. This study shows the ability of 19F MRI to selectively map the bio-distribution of 19F-BPA in a C6 rat glioma model, as well as providing a useful method to perform pharmacokinetics of BNCT carriers.

Original languageEnglish
Pages (from-to)6979-6989
Number of pages11
JournalPhysics in Medicine and Biology
Volume53
Issue number23
DOIs
Publication statusPublished - Dec 7 2008

Fingerprint

Boron Neutron Capture Therapy
Fructose
Glioma
Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging
Pharmacokinetics
Neutrons
Brain

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

In vivo 19F MRI and 19F MRS of 19F- labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT). / Porcari, Paola; Capuani, Silvia; D'Amore, Emanuela; Lecce, Mario; La Bella, Angela; Fasano, Fabrizio; Campanella, Renzo; Migneco, Luisa Maria; Pastore, Francesco Saverio; Maraviglia, Bruno.

In: Physics in Medicine and Biology, Vol. 53, No. 23, 07.12.2008, p. 6979-6989.

Research output: Contribution to journalArticle

Porcari, P, Capuani, S, D'Amore, E, Lecce, M, La Bella, A, Fasano, F, Campanella, R, Migneco, LM, Pastore, FS & Maraviglia, B 2008, 'In vivo 19F MRI and 19F MRS of 19F- labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT)', Physics in Medicine and Biology, vol. 53, no. 23, pp. 6979-6989. https://doi.org/10.1088/0031-9155/53/23/021
Porcari, Paola ; Capuani, Silvia ; D'Amore, Emanuela ; Lecce, Mario ; La Bella, Angela ; Fasano, Fabrizio ; Campanella, Renzo ; Migneco, Luisa Maria ; Pastore, Francesco Saverio ; Maraviglia, Bruno. / In vivo 19F MRI and 19F MRS of 19F- labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT). In: Physics in Medicine and Biology. 2008 ; Vol. 53, No. 23. pp. 6979-6989.
@article{aaf4c7d280b6404389f57f5d85910592,
title = "In vivo 19F MRI and 19F MRS of 19F- labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT)",
abstract = "Boron neutron capture therapy (BNCT) is a promising binary modality used to treat malignant brain gliomas. To optimize BNCT effectiveness a non-invasive method is needed to monitor the spatial distribution of BNCT carriers in order to estimate the optimal timing for neutron irradiation. In this study, in vivo spatial distribution mapping and pharmacokinetics evaluation of the 19F-labelled boronophenylalanine (BPA) were performed using 19F magnetic resonance imaging (19F MRI) and 19F magnetic resonance spectroscopy (19F MRS). Characteristic uptake of 19F-BPA in C6 glioma showed a maximum at 2.5 h after compound infusion as confirmed by both 19F images and 19F spectra acquired on blood samples collected at different times after infusion. This study shows the ability of 19F MRI to selectively map the bio-distribution of 19F-BPA in a C6 rat glioma model, as well as providing a useful method to perform pharmacokinetics of BNCT carriers.",
author = "Paola Porcari and Silvia Capuani and Emanuela D'Amore and Mario Lecce and {La Bella}, Angela and Fabrizio Fasano and Renzo Campanella and Migneco, {Luisa Maria} and Pastore, {Francesco Saverio} and Bruno Maraviglia",
year = "2008",
month = "12",
day = "7",
doi = "10.1088/0031-9155/53/23/021",
language = "English",
volume = "53",
pages = "6979--6989",
journal = "Physics in Medicine and Biology",
issn = "0031-9155",
publisher = "IOP Publishing Ltd.",
number = "23",

}

TY - JOUR

T1 - In vivo 19F MRI and 19F MRS of 19F- labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT)

AU - Porcari, Paola

AU - Capuani, Silvia

AU - D'Amore, Emanuela

AU - Lecce, Mario

AU - La Bella, Angela

AU - Fasano, Fabrizio

AU - Campanella, Renzo

AU - Migneco, Luisa Maria

AU - Pastore, Francesco Saverio

AU - Maraviglia, Bruno

PY - 2008/12/7

Y1 - 2008/12/7

N2 - Boron neutron capture therapy (BNCT) is a promising binary modality used to treat malignant brain gliomas. To optimize BNCT effectiveness a non-invasive method is needed to monitor the spatial distribution of BNCT carriers in order to estimate the optimal timing for neutron irradiation. In this study, in vivo spatial distribution mapping and pharmacokinetics evaluation of the 19F-labelled boronophenylalanine (BPA) were performed using 19F magnetic resonance imaging (19F MRI) and 19F magnetic resonance spectroscopy (19F MRS). Characteristic uptake of 19F-BPA in C6 glioma showed a maximum at 2.5 h after compound infusion as confirmed by both 19F images and 19F spectra acquired on blood samples collected at different times after infusion. This study shows the ability of 19F MRI to selectively map the bio-distribution of 19F-BPA in a C6 rat glioma model, as well as providing a useful method to perform pharmacokinetics of BNCT carriers.

AB - Boron neutron capture therapy (BNCT) is a promising binary modality used to treat malignant brain gliomas. To optimize BNCT effectiveness a non-invasive method is needed to monitor the spatial distribution of BNCT carriers in order to estimate the optimal timing for neutron irradiation. In this study, in vivo spatial distribution mapping and pharmacokinetics evaluation of the 19F-labelled boronophenylalanine (BPA) were performed using 19F magnetic resonance imaging (19F MRI) and 19F magnetic resonance spectroscopy (19F MRS). Characteristic uptake of 19F-BPA in C6 glioma showed a maximum at 2.5 h after compound infusion as confirmed by both 19F images and 19F spectra acquired on blood samples collected at different times after infusion. This study shows the ability of 19F MRI to selectively map the bio-distribution of 19F-BPA in a C6 rat glioma model, as well as providing a useful method to perform pharmacokinetics of BNCT carriers.

UR - http://www.scopus.com/inward/record.url?scp=58149216495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149216495&partnerID=8YFLogxK

U2 - 10.1088/0031-9155/53/23/021

DO - 10.1088/0031-9155/53/23/021

M3 - Article

C2 - 19001698

AN - SCOPUS:58149216495

VL - 53

SP - 6979

EP - 6989

JO - Physics in Medicine and Biology

JF - Physics in Medicine and Biology

SN - 0031-9155

IS - 23

ER -